Sensing α-Synuclein From the Outside via the Prion Protein

Implications for Neurodegeneration

Inês Caldeira Brás, Luísa V. Lopes, Tiago Fleming Outeiro

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Parkinson's disease and other synucleinopathies are characterized by the accumulation of aggregated α-synuclein in intracellular proteinaceous inclusions. The progressive nature of synucleinopathies seems to be related to the cell-to-cell spreading of α-synuclein pathology, and several possible mechanisms have been put forward to explain this phenomenon. In our recent study, we found that α-synuclein oligomers interact with cellular prion protein in glutamatergic synapses. This interaction triggered a signaling cascade involving phosphorylation of Fyn kinase and activation of the N-methyl-d-aspartate receptor, thereby leading to synaptic dysfunction. Here, we present relevant plasma membrane proteins that have been described to interact with α-synuclein and discuss the possible pathological implications. We focus primarily on the prion protein and propose a pathological mechanism in which the interaction between α-synuclein and prion protein leads to the formation of cofilin/actin rods, culminating in long-term potentiation impairment and cognitive dysfunction. We posit that deciphering the mechanisms involved in sensing specific forms of extracellular α-synuclein and transducing this information may prove invaluable in our quest to devise novel diagnostic and therapeutic approaches in PD and other synucleinopathies.

Original languageEnglish
Pages (from-to)1675-1684
Number of pages10
JournalMovement Disorders
Volume33
Issue number11
DOIs
Publication statusPublished - 1 Nov 2018

Fingerprint

Synucleins
Actin Depolymerizing Factors
Long-Term Potentiation
Synapses
Parkinson Disease
Prion Proteins
Actins
Blood Proteins
Membrane Proteins
Phosphotransferases
Phosphorylation
Cell Membrane
Pathology

Keywords

  • Parkinson's disease
  • prion
  • receptor
  • spreading
  • synucleinopathy
  • α-synuclein

Cite this

@article{fc428c20e9e94c058f4b547e8f20f8a2,
title = "Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration",
abstract = "Parkinson's disease and other synucleinopathies are characterized by the accumulation of aggregated α-synuclein in intracellular proteinaceous inclusions. The progressive nature of synucleinopathies seems to be related to the cell-to-cell spreading of α-synuclein pathology, and several possible mechanisms have been put forward to explain this phenomenon. In our recent study, we found that α-synuclein oligomers interact with cellular prion protein in glutamatergic synapses. This interaction triggered a signaling cascade involving phosphorylation of Fyn kinase and activation of the N-methyl-d-aspartate receptor, thereby leading to synaptic dysfunction. Here, we present relevant plasma membrane proteins that have been described to interact with α-synuclein and discuss the possible pathological implications. We focus primarily on the prion protein and propose a pathological mechanism in which the interaction between α-synuclein and prion protein leads to the formation of cofilin/actin rods, culminating in long-term potentiation impairment and cognitive dysfunction. We posit that deciphering the mechanisms involved in sensing specific forms of extracellular α-synuclein and transducing this information may prove invaluable in our quest to devise novel diagnostic and therapeutic approaches in PD and other synucleinopathies.",
keywords = "Parkinson's disease, prion, receptor, spreading, synucleinopathy, α-synuclein",
author = "Br{\'a}s, {In{\^e}s Caldeira} and Lopes, {Lu{\'i}sa V.} and Outeiro, {Tiago Fleming}",
year = "2018",
month = "11",
day = "1",
doi = "10.1002/mds.27478",
language = "English",
volume = "33",
pages = "1675--1684",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

Sensing α-Synuclein From the Outside via the Prion Protein : Implications for Neurodegeneration. / Brás, Inês Caldeira; Lopes, Luísa V.; Outeiro, Tiago Fleming.

In: Movement Disorders, Vol. 33, No. 11, 01.11.2018, p. 1675-1684.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sensing α-Synuclein From the Outside via the Prion Protein

T2 - Implications for Neurodegeneration

AU - Brás, Inês Caldeira

AU - Lopes, Luísa V.

AU - Outeiro, Tiago Fleming

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Parkinson's disease and other synucleinopathies are characterized by the accumulation of aggregated α-synuclein in intracellular proteinaceous inclusions. The progressive nature of synucleinopathies seems to be related to the cell-to-cell spreading of α-synuclein pathology, and several possible mechanisms have been put forward to explain this phenomenon. In our recent study, we found that α-synuclein oligomers interact with cellular prion protein in glutamatergic synapses. This interaction triggered a signaling cascade involving phosphorylation of Fyn kinase and activation of the N-methyl-d-aspartate receptor, thereby leading to synaptic dysfunction. Here, we present relevant plasma membrane proteins that have been described to interact with α-synuclein and discuss the possible pathological implications. We focus primarily on the prion protein and propose a pathological mechanism in which the interaction between α-synuclein and prion protein leads to the formation of cofilin/actin rods, culminating in long-term potentiation impairment and cognitive dysfunction. We posit that deciphering the mechanisms involved in sensing specific forms of extracellular α-synuclein and transducing this information may prove invaluable in our quest to devise novel diagnostic and therapeutic approaches in PD and other synucleinopathies.

AB - Parkinson's disease and other synucleinopathies are characterized by the accumulation of aggregated α-synuclein in intracellular proteinaceous inclusions. The progressive nature of synucleinopathies seems to be related to the cell-to-cell spreading of α-synuclein pathology, and several possible mechanisms have been put forward to explain this phenomenon. In our recent study, we found that α-synuclein oligomers interact with cellular prion protein in glutamatergic synapses. This interaction triggered a signaling cascade involving phosphorylation of Fyn kinase and activation of the N-methyl-d-aspartate receptor, thereby leading to synaptic dysfunction. Here, we present relevant plasma membrane proteins that have been described to interact with α-synuclein and discuss the possible pathological implications. We focus primarily on the prion protein and propose a pathological mechanism in which the interaction between α-synuclein and prion protein leads to the formation of cofilin/actin rods, culminating in long-term potentiation impairment and cognitive dysfunction. We posit that deciphering the mechanisms involved in sensing specific forms of extracellular α-synuclein and transducing this information may prove invaluable in our quest to devise novel diagnostic and therapeutic approaches in PD and other synucleinopathies.

KW - Parkinson's disease

KW - prion

KW - receptor

KW - spreading

KW - synucleinopathy

KW - α-synuclein

UR - http://www.scopus.com/inward/record.url?scp=85056454715&partnerID=8YFLogxK

U2 - 10.1002/mds.27478

DO - 10.1002/mds.27478

M3 - Article

VL - 33

SP - 1675

EP - 1684

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 11

ER -